

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of multicellular organism growth (GO:0040015) | 9.52479490 |
| 2 | regulation of establishment of cell polarity (GO:2000114) | 8.71877562 |
| 3 | cytoplasmic mRNA processing body assembly (GO:0033962) | 8.61367483 |
| 4 | regulation of MHC class I biosynthetic process (GO:0045343) | 8.36615989 |
| 5 | sex differentiation (GO:0007548) | 8.17905733 |
| 6 | negative regulation of type 2 immune response (GO:0002829) | 7.66772798 |
| 7 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 7.06133764 |
| 8 | sterol catabolic process (GO:0016127) | 6.67914492 |
| 9 | cholesterol catabolic process (GO:0006707) | 6.67914492 |
| 10 | regulation of interleukin-13 production (GO:0032656) | 6.38568770 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.26125651 |
| 12 | positive regulation of vasculogenesis (GO:2001214) | 6.24345669 |
| 13 | ADP metabolic process (GO:0046031) | 6.13271001 |
| 14 | stress granule assembly (GO:0034063) | 6.09405009 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.97142845 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.97142845 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.97142845 |
| 18 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.93811411 |
| 19 | alternative mRNA splicing, via spliceosome (GO:0000380) | 5.56839550 |
| 20 | regulation of interleukin-5 production (GO:0032674) | 5.54256295 |
| 21 | nucleoside diphosphate catabolic process (GO:0009134) | 5.51515683 |
| 22 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 5.21791664 |
| 23 | tryptophan metabolic process (GO:0006568) | 5.04491620 |
| 24 | regulation of vasculogenesis (GO:2001212) | 4.95508428 |
| 25 | centrosome duplication (GO:0051298) | 4.65871843 |
| 26 | bile acid biosynthetic process (GO:0006699) | 4.61662735 |
| 27 | indolalkylamine metabolic process (GO:0006586) | 4.48228182 |
| 28 | lipid particle organization (GO:0034389) | 4.42365817 |
| 29 | regulation of metalloenzyme activity (GO:0048552) | 4.38657814 |
| 30 | regulation of action potential (GO:0098900) | 4.31704252 |
| 31 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.09532637 |
| 32 | negative regulation of mast cell activation (GO:0033004) | 3.93190305 |
| 33 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.89034536 |
| 34 | amine catabolic process (GO:0009310) | 3.88427361 |
| 35 | cellular biogenic amine catabolic process (GO:0042402) | 3.88427361 |
| 36 | acrosome assembly (GO:0001675) | 3.87833928 |
| 37 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.84235496 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 3.78204593 |
| 39 | neuronal action potential propagation (GO:0019227) | 3.74403888 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 3.71574995 |
| 41 | neural tube formation (GO:0001841) | 3.57716322 |
| 42 | synaptic transmission, cholinergic (GO:0007271) | 3.57493907 |
| 43 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.53108243 |
| 44 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.52289667 |
| 45 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.52289667 |
| 46 | central nervous system neuron axonogenesis (GO:0021955) | 3.47895751 |
| 47 | somite rostral/caudal axis specification (GO:0032525) | 3.47538314 |
| 48 | NAD biosynthetic process (GO:0009435) | 3.46994563 |
| 49 | piRNA metabolic process (GO:0034587) | 3.40402074 |
| 50 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.40133753 |
| 51 | lipid translocation (GO:0034204) | 3.38223121 |
| 52 | phospholipid translocation (GO:0045332) | 3.38223121 |
| 53 | response to X-ray (GO:0010165) | 3.37322145 |
| 54 | L-methionine salvage (GO:0071267) | 3.37065983 |
| 55 | L-methionine biosynthetic process (GO:0071265) | 3.37065983 |
| 56 | amino acid salvage (GO:0043102) | 3.37065983 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 3.35405147 |
| 58 | estrogen biosynthetic process (GO:0006703) | 3.33636228 |
| 59 | L-fucose catabolic process (GO:0042355) | 3.31031631 |
| 60 | fucose catabolic process (GO:0019317) | 3.31031631 |
| 61 | L-fucose metabolic process (GO:0042354) | 3.31031631 |
| 62 | auditory receptor cell stereocilium organization (GO:0060088) | 3.20052293 |
| 63 | seminiferous tubule development (GO:0072520) | 3.16510761 |
| 64 | negative regulation of endothelial cell proliferation (GO:0001937) | 3.14819940 |
| 65 | steroid catabolic process (GO:0006706) | 3.13210630 |
| 66 | protein autoprocessing (GO:0016540) | 3.12058247 |
| 67 | ketone body metabolic process (GO:1902224) | 3.09865015 |
| 68 | regulation of gene silencing by RNA (GO:0060966) | 3.09422056 |
| 69 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.09422056 |
| 70 | regulation of gene silencing by miRNA (GO:0060964) | 3.09422056 |
| 71 | one-carbon compound transport (GO:0019755) | 3.07262285 |
| 72 | indole-containing compound metabolic process (GO:0042430) | 3.07076602 |
| 73 | negative regulation of T cell differentiation (GO:0045581) | 3.04210533 |
| 74 | regulation of sequestering of triglyceride (GO:0010889) | 3.03791749 |
| 75 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.98347406 |
| 76 | detection of light stimulus involved in visual perception (GO:0050908) | 2.97904061 |
| 77 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.97904061 |
| 78 | positive regulation of heat generation (GO:0031652) | 2.96244680 |
| 79 | behavioral response to ethanol (GO:0048149) | 2.95547601 |
| 80 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.93801264 |
| 81 | negative regulation of organ growth (GO:0046621) | 2.92612962 |
| 82 | aromatic amino acid family metabolic process (GO:0009072) | 2.89969709 |
| 83 | regulation of receptor internalization (GO:0002090) | 2.88174739 |
| 84 | killing of cells of other organism (GO:0031640) | 2.87716400 |
| 85 | disruption of cells of other organism (GO:0044364) | 2.87716400 |
| 86 | metallo-sulfur cluster assembly (GO:0031163) | 2.84107465 |
| 87 | iron-sulfur cluster assembly (GO:0016226) | 2.84107465 |
| 88 | cell differentiation in hindbrain (GO:0021533) | 2.83758746 |
| 89 | regulation of superoxide metabolic process (GO:0090322) | 2.82292417 |
| 90 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.82181602 |
| 91 | regulation of collateral sprouting (GO:0048670) | 2.81508526 |
| 92 | histone H3-K4 trimethylation (GO:0080182) | 2.80501657 |
| 93 | methionine biosynthetic process (GO:0009086) | 2.80296632 |
| 94 | DNA methylation involved in gamete generation (GO:0043046) | 2.79052690 |
| 95 | cardiolipin metabolic process (GO:0032048) | 2.78237251 |
| 96 | regulation of sarcomere organization (GO:0060297) | 2.77960575 |
| 97 | adult walking behavior (GO:0007628) | 2.75635897 |
| 98 | DNA demethylation (GO:0080111) | 2.75377157 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 2.74127614 |
| 100 | regulation of memory T cell differentiation (GO:0043380) | 10.4079223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.57110611 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.22235695 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.89326516 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.38040933 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.26345497 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.98113008 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.74024520 |
| 8 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.73837546 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.60599518 |
| 10 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.45073642 |
| 11 | BCAT_22108803_ChIP-Seq_LS180_Human | 2.43121363 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.42865236 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.42198428 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.38744627 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.28566352 |
| 16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.27308125 |
| 17 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09723343 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.00419156 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96412549 |
| 20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95890139 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.90440050 |
| 22 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.89691163 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.88507845 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86988616 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.82204126 |
| 26 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.74189410 |
| 27 | STAT3_23295773_ChIP-Seq_U87_Human | 1.65216193 |
| 28 | AR_25329375_ChIP-Seq_VCAP_Human | 1.63525180 |
| 29 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.61499592 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.60000604 |
| 31 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58895199 |
| 32 | TCF4_23295773_ChIP-Seq_U87_Human | 1.56640352 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55225964 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52234146 |
| 35 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.46654158 |
| 36 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46654158 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45947397 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43743114 |
| 39 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42674553 |
| 40 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.42557273 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.42493115 |
| 42 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.42137778 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37961905 |
| 44 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.37182077 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34742635 |
| 46 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34146589 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.32476338 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.32476338 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31889767 |
| 50 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31490956 |
| 51 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.30560556 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29140302 |
| 53 | KDM2B_26808549_Chip-Seq_REH_Human | 1.28507731 |
| 54 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26994979 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25721595 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25588828 |
| 57 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23492704 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22813681 |
| 59 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21727071 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21051311 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20320005 |
| 62 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19700401 |
| 63 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17741184 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17699860 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15472765 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14245971 |
| 67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14102655 |
| 68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13752238 |
| 69 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13414923 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13023570 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12562477 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12562477 |
| 73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11467174 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10721429 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10211094 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10031281 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09551828 |
| 78 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07065909 |
| 79 | NCOR_22424771_ChIP-Seq_293T_Human | 1.06307422 |
| 80 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05836446 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05016181 |
| 82 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04156813 |
| 83 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03787688 |
| 84 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03372581 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02848018 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02828198 |
| 87 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01373621 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01279489 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99002316 |
| 90 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98900274 |
| 91 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98897493 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97490067 |
| 93 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97472087 |
| 94 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96982877 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95498828 |
| 96 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95339337 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94888729 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93051383 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92899254 |
| 100 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92899254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003252_abnormal_bile_duct | 5.63201914 |
| 2 | MP0003011_delayed_dark_adaptation | 5.12790667 |
| 3 | MP0002736_abnormal_nociception_after | 4.71435315 |
| 4 | MP0000569_abnormal_digit_pigmentation | 4.53595883 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.86575038 |
| 6 | MP0001986_abnormal_taste_sensitivity | 3.38664749 |
| 7 | MP0003195_calcinosis | 2.69431940 |
| 8 | MP0000371_diluted_coat_color | 2.57877864 |
| 9 | MP0001501_abnormal_sleep_pattern | 2.43495038 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.42922758 |
| 11 | MP0002234_abnormal_pharynx_morphology | 2.34434028 |
| 12 | MP0005551_abnormal_eye_electrophysiolog | 2.29661155 |
| 13 | MP0009745_abnormal_behavioral_response | 2.29504907 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.24903444 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.19215333 |
| 16 | MP0005253_abnormal_eye_physiology | 2.18588437 |
| 17 | MP0002102_abnormal_ear_morphology | 2.11106192 |
| 18 | MP0009046_muscle_twitch | 1.93540596 |
| 19 | MP0003646_muscle_fatigue | 1.91129287 |
| 20 | MP0000427_abnormal_hair_cycle | 1.87090629 |
| 21 | MP0005647_abnormal_sex_gland | 1.81822984 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 1.77981472 |
| 23 | MP0010386_abnormal_urinary_bladder | 1.73766976 |
| 24 | MP0003718_maternal_effect | 1.61900406 |
| 25 | MP0002272_abnormal_nervous_system | 1.52963816 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.51333342 |
| 27 | MP0005171_absent_coat_pigmentation | 1.50305612 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.44050949 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.43758759 |
| 30 | MP0005310_abnormal_salivary_gland | 1.42924637 |
| 31 | MP0001486_abnormal_startle_reflex | 1.42867008 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.41301360 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.41147404 |
| 34 | MP0000383_abnormal_hair_follicle | 1.38445058 |
| 35 | MP0004130_abnormal_muscle_cell | 1.37049167 |
| 36 | MP0005410_abnormal_fertilization | 1.33675065 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.33274239 |
| 38 | MP0002064_seizures | 1.27395616 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.24999200 |
| 40 | MP0004043_abnormal_pH_regulation | 1.21552315 |
| 41 | MP0003186_abnormal_redox_activity | 1.17291679 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.14927398 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.14213311 |
| 44 | MP0002282_abnormal_trachea_morphology | 1.11942485 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.09535503 |
| 46 | MP0005334_abnormal_fat_pad | 1.08512980 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.06324846 |
| 48 | MP0004147_increased_porphyrin_level | 1.05905328 |
| 49 | MP0002693_abnormal_pancreas_physiology | 1.05017566 |
| 50 | MP0004924_abnormal_behavior | 1.04725366 |
| 51 | MP0005386_behavior/neurological_phenoty | 1.04725366 |
| 52 | MP0003119_abnormal_digestive_system | 1.04576430 |
| 53 | MP0002075_abnormal_coat/hair_pigmentati | 1.03348833 |
| 54 | MP0001764_abnormal_homeostasis | 1.01385432 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.00075399 |
| 56 | MP0002067_abnormal_sensory_capabilities | 0.94906427 |
| 57 | MP0008877_abnormal_DNA_methylation | 0.92680686 |
| 58 | MP0008872_abnormal_physiological_respon | 0.90626454 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 0.90003137 |
| 60 | MP0000653_abnormal_sex_gland | 0.89012078 |
| 61 | MP0003880_abnormal_central_pattern | 0.88709459 |
| 62 | MP0001970_abnormal_pain_threshold | 0.88426324 |
| 63 | MP0002160_abnormal_reproductive_system | 0.88331461 |
| 64 | MP0006276_abnormal_autonomic_nervous | 0.88171779 |
| 65 | MP0004381_abnormal_hair_follicle | 0.88002000 |
| 66 | MP0004885_abnormal_endolymph | 0.87127673 |
| 67 | MP0002638_abnormal_pupillary_reflex | 0.86885866 |
| 68 | MP0003136_yellow_coat_color | 0.86017947 |
| 69 | MP0002229_neurodegeneration | 0.81173950 |
| 70 | MP0001324_abnormal_eye_pigmentation | 0.80272589 |
| 71 | MP0002163_abnormal_gland_morphology | 0.80230367 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 0.78968615 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 0.78806467 |
| 74 | MP0004742_abnormal_vestibular_system | 0.77367641 |
| 75 | MP0005083_abnormal_biliary_tract | 0.76939150 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.73681931 |
| 77 | MP0005395_other_phenotype | 0.72751166 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.72676512 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.71002716 |
| 80 | MP0003935_abnormal_craniofacial_develop | 0.70821901 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.70626669 |
| 82 | MP0002572_abnormal_emotion/affect_behav | 0.70224018 |
| 83 | MP0001145_abnormal_male_reproductive | 0.70051812 |
| 84 | MP0005670_abnormal_white_adipose | 0.69573635 |
| 85 | MP0006036_abnormal_mitochondrial_physio | 0.69346841 |
| 86 | MP0002938_white_spotting | 0.68412067 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67877868 |
| 88 | MP0009250_abnormal_appendicular_skeleto | 0.67160255 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.67051849 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.66424715 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 0.66015447 |
| 92 | MP0000516_abnormal_urinary_system | 0.66015447 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 0.65779438 |
| 94 | MP0003698_abnormal_male_reproductive | 0.65654562 |
| 95 | MP0001664_abnormal_digestion | 0.64064915 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.62637819 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.62595543 |
| 98 | MP0000749_muscle_degeneration | 0.62017090 |
| 99 | MP0001944_abnormal_pancreas_morphology | 0.61745994 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.61473817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 9.73465051 |
| 2 | Dysmetric saccades (HP:0000641) | 8.46874364 |
| 3 | Action tremor (HP:0002345) | 8.17283435 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 7.46907449 |
| 5 | Prostate neoplasm (HP:0100787) | 6.99127329 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 5.84380147 |
| 7 | Pendular nystagmus (HP:0012043) | 5.19159687 |
| 8 | Absence seizures (HP:0002121) | 5.18271382 |
| 9 | Abnormality of the hepatic vasculature (HP:0006707) | 4.74549740 |
| 10 | Urinary bladder sphincter dysfunction (HP:0002839) | 4.66166668 |
| 11 | Dialeptic seizures (HP:0011146) | 4.42002535 |
| 12 | Focal seizures (HP:0007359) | 4.40377866 |
| 13 | Dysdiadochokinesis (HP:0002075) | 4.19625617 |
| 14 | Postural instability (HP:0002172) | 4.08160464 |
| 15 | Severe visual impairment (HP:0001141) | 3.99394303 |
| 16 | Postural tremor (HP:0002174) | 3.98741625 |
| 17 | Slow saccadic eye movements (HP:0000514) | 3.79803629 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.77101353 |
| 19 | Hyperventilation (HP:0002883) | 3.74724770 |
| 20 | Impaired vibratory sensation (HP:0002495) | 3.71579147 |
| 21 | Abnormality of the prostate (HP:0008775) | 3.66171928 |
| 22 | Abnormality of macular pigmentation (HP:0008002) | 3.57099810 |
| 23 | Focal motor seizures (HP:0011153) | 3.55650096 |
| 24 | Limb ataxia (HP:0002070) | 3.50449680 |
| 25 | Impaired smooth pursuit (HP:0007772) | 3.36731987 |
| 26 | Pancreatic cysts (HP:0001737) | 3.07031952 |
| 27 | Increased corneal curvature (HP:0100692) | 2.86613430 |
| 28 | Keratoconus (HP:0000563) | 2.86613430 |
| 29 | Impaired proprioception (HP:0010831) | 2.76646428 |
| 30 | Chorioretinal atrophy (HP:0000533) | 2.60444078 |
| 31 | Pancreatic fibrosis (HP:0100732) | 2.58175365 |
| 32 | True hermaphroditism (HP:0010459) | 2.57290435 |
| 33 | Retinitis pigmentosa (HP:0000510) | 2.52634675 |
| 34 | Febrile seizures (HP:0002373) | 2.51726860 |
| 35 | Fair hair (HP:0002286) | 2.44732338 |
| 36 | Oculomotor apraxia (HP:0000657) | 2.40576700 |
| 37 | Clumsiness (HP:0002312) | 2.38727276 |
| 38 | Vitreoretinal degeneration (HP:0000655) | 2.36824892 |
| 39 | Bilateral microphthalmos (HP:0007633) | 2.30866185 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.29252465 |
| 41 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26976711 |
| 42 | Areflexia of lower limbs (HP:0002522) | 2.26152393 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 2.25744558 |
| 44 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.25744558 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.25492155 |
| 46 | Abnormality of midbrain morphology (HP:0002418) | 2.25492155 |
| 47 | Absent speech (HP:0001344) | 2.24162552 |
| 48 | Postnatal microcephaly (HP:0005484) | 2.23945961 |
| 49 | Proximal tubulopathy (HP:0000114) | 2.20326620 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.18905418 |
| 51 | Atonic seizures (HP:0010819) | 2.17950853 |
| 52 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17451174 |
| 53 | Abnormality of male internal genitalia (HP:0000022) | 2.16949674 |
| 54 | Attenuation of retinal blood vessels (HP:0007843) | 2.16083006 |
| 55 | Abnormality of vision evoked potentials (HP:0000649) | 2.15450849 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.13199798 |
| 57 | Severe Myopia (HP:0011003) | 2.13146938 |
| 58 | Nephronophthisis (HP:0000090) | 2.12264015 |
| 59 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.12241474 |
| 60 | Abnormality of the renal cortex (HP:0011035) | 2.11853987 |
| 61 | Hypochromic anemia (HP:0001931) | 2.10776843 |
| 62 | Inability to walk (HP:0002540) | 2.09761840 |
| 63 | Biliary tract neoplasm (HP:0100574) | 2.09013553 |
| 64 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08514863 |
| 65 | Abnormal ciliary motility (HP:0012262) | 2.02432968 |
| 66 | Protruding tongue (HP:0010808) | 2.00678603 |
| 67 | Decreased muscle mass (HP:0003199) | 1.97411165 |
| 68 | Rib fusion (HP:0000902) | 1.97039382 |
| 69 | Hemiparesis (HP:0001269) | 1.91944756 |
| 70 | Decreased central vision (HP:0007663) | 1.89961221 |
| 71 | Hypoplasia of the fovea (HP:0007750) | 1.88955804 |
| 72 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88955804 |
| 73 | Sclerocornea (HP:0000647) | 1.84833187 |
| 74 | Generalized hypopigmentation of hair (HP:0011358) | 1.83302006 |
| 75 | Abnormality of the renal medulla (HP:0100957) | 1.81119267 |
| 76 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.79310296 |
| 77 | Facial diplegia (HP:0001349) | 1.78100695 |
| 78 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77667322 |
| 79 | Cystic liver disease (HP:0006706) | 1.77374652 |
| 80 | Disproportionate short-trunk short stature (HP:0003521) | 1.77012218 |
| 81 | Portal hypertension (HP:0001409) | 1.76745571 |
| 82 | Macular degeneration (HP:0000608) | 1.75329842 |
| 83 | Tinnitus (HP:0000360) | 1.73984347 |
| 84 | Tubular atrophy (HP:0000092) | 1.70842441 |
| 85 | Abnormality of saccadic eye movements (HP:0000570) | 1.70150854 |
| 86 | Broad-based gait (HP:0002136) | 1.68542139 |
| 87 | Horizontal nystagmus (HP:0000666) | 1.68467803 |
| 88 | Renal cortical cysts (HP:0000803) | 1.67004790 |
| 89 | Hypoproteinemia (HP:0003075) | 1.66346702 |
| 90 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.65835263 |
| 91 | Hyperthyroidism (HP:0000836) | 1.65279140 |
| 92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.64695078 |
| 93 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.64580604 |
| 94 | Chromsome breakage (HP:0040012) | 1.64041417 |
| 95 | Hyperglycinuria (HP:0003108) | 1.60272816 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 1.60098653 |
| 97 | Abnormality of alanine metabolism (HP:0010916) | 1.59322703 |
| 98 | Hyperalaninemia (HP:0003348) | 1.59322703 |
| 99 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59322703 |
| 100 | Progressive inability to walk (HP:0002505) | 1.58060510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK19 | 8.70230682 |
| 2 | FRK | 7.91353891 |
| 3 | OXSR1 | 5.17908320 |
| 4 | ACVR1B | 3.09326477 |
| 5 | BMPR1B | 2.83380832 |
| 6 | TNK2 | 2.44816669 |
| 7 | GRK1 | 2.30830494 |
| 8 | MAP3K7 | 1.98734162 |
| 9 | ADRBK2 | 1.93022591 |
| 10 | PINK1 | 1.79888340 |
| 11 | MKNK2 | 1.66816191 |
| 12 | ZAK | 1.51997880 |
| 13 | NEK1 | 1.48556530 |
| 14 | BCR | 1.47987882 |
| 15 | NUAK1 | 1.46850511 |
| 16 | FER | 1.44974236 |
| 17 | INSRR | 1.41364236 |
| 18 | WNK3 | 1.34134554 |
| 19 | TXK | 1.33909847 |
| 20 | MAP4K2 | 1.29420757 |
| 21 | STK3 | 1.23479141 |
| 22 | STK38L | 1.23305185 |
| 23 | CASK | 1.19004892 |
| 24 | TGFBR1 | 1.15669691 |
| 25 | MAPK13 | 1.01620620 |
| 26 | TAOK3 | 0.99177657 |
| 27 | MKNK1 | 0.97510813 |
| 28 | RPS6KB2 | 0.94818705 |
| 29 | VRK2 | 0.89690828 |
| 30 | STK38 | 0.87298458 |
| 31 | TAF1 | 0.82578082 |
| 32 | ADRBK1 | 0.79497018 |
| 33 | STK11 | 0.78121311 |
| 34 | TRIM28 | 0.70378255 |
| 35 | MAPKAPK5 | 0.66465146 |
| 36 | TNIK | 0.57743377 |
| 37 | ALK | 0.55799495 |
| 38 | PTK2B | 0.55053847 |
| 39 | PRKAA2 | 0.54053736 |
| 40 | WNK4 | 0.52313078 |
| 41 | DAPK2 | 0.52011411 |
| 42 | MAP3K4 | 0.51527857 |
| 43 | BRSK2 | 0.50825231 |
| 44 | TIE1 | 0.50481870 |
| 45 | PAK3 | 0.49233167 |
| 46 | CSNK1G2 | 0.49158982 |
| 47 | PRKCE | 0.46862056 |
| 48 | PLK2 | 0.46610657 |
| 49 | PRKCG | 0.46310745 |
| 50 | CHEK2 | 0.45993860 |
| 51 | MUSK | 0.45708986 |
| 52 | MARK1 | 0.45026844 |
| 53 | TEC | 0.44851881 |
| 54 | CSNK1G1 | 0.43784160 |
| 55 | PIK3CG | 0.43023503 |
| 56 | CAMKK2 | 0.42493861 |
| 57 | NTRK3 | 0.41617077 |
| 58 | STK39 | 0.40565236 |
| 59 | PLK4 | 0.38923423 |
| 60 | VRK1 | 0.37216100 |
| 61 | CSNK1A1L | 0.35934942 |
| 62 | LATS1 | 0.34967380 |
| 63 | CSNK1G3 | 0.34939067 |
| 64 | GRK5 | 0.33377094 |
| 65 | NEK2 | 0.32566075 |
| 66 | PIK3CA | 0.31902165 |
| 67 | CAMK2A | 0.30107300 |
| 68 | EIF2AK3 | 0.29859700 |
| 69 | PDK1 | 0.29709248 |
| 70 | CSNK1A1 | 0.28521963 |
| 71 | OBSCN | 0.26775544 |
| 72 | MAP2K7 | 0.26195818 |
| 73 | PRKG1 | 0.25219579 |
| 74 | AKT3 | 0.24973106 |
| 75 | EPHA4 | 0.24593915 |
| 76 | ERBB3 | 0.23624631 |
| 77 | PRKD3 | 0.22387893 |
| 78 | ERBB2 | 0.22314071 |
| 79 | MELK | 0.21966203 |
| 80 | PRKAA1 | 0.21159133 |
| 81 | MAP2K1 | 0.20637178 |
| 82 | CHEK1 | 0.20256269 |
| 83 | PRKACA | 0.19817811 |
| 84 | PDPK1 | 0.19792063 |
| 85 | BCKDK | 0.19774302 |
| 86 | PIM2 | 0.19726082 |
| 87 | PKN1 | 0.19660798 |
| 88 | CDK5 | 0.16777585 |
| 89 | JAK2 | 0.16315811 |
| 90 | CSNK1D | 0.15726134 |
| 91 | MATK | 0.15610800 |
| 92 | PRKCA | 0.15119988 |
| 93 | MAP2K6 | 0.12965482 |
| 94 | RPS6KB1 | 0.12874152 |
| 95 | FGFR2 | 0.12864483 |
| 96 | PRKCI | 0.12852747 |
| 97 | PLK3 | 0.12716223 |
| 98 | IGF1R | 0.12138801 |
| 99 | ABL1 | 0.10791528 |
| 100 | CDK18 | 0.09550337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 7.07233363 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.40038533 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.55566079 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41105730 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.40323729 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.32052102 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26097414 |
| 8 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.12201544 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06354257 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.06218847 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.02845075 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.02521668 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.00832303 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.00153762 |
| 15 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.98723899 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.98575138 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.94955210 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.94925149 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80256565 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.79947474 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.78886842 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63109985 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37094520 |
| 24 | Nicotine addiction_Homo sapiens_hsa05033 | 1.34082472 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.29277253 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25515173 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.24716206 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22340415 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21627232 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15002870 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.14451371 |
| 32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12651734 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.10722778 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.08514107 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03786060 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 0.99627537 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99368681 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 0.89943197 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.89629923 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88895813 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.88177167 |
| 42 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86751027 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85625419 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84137403 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82775822 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80601293 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80528803 |
| 48 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80320908 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79278566 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76953414 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75835875 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.75806656 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75121401 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75104746 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 0.74503270 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73859199 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71816177 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69766204 |
| 59 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.68690423 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64561410 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64401138 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63627950 |
| 63 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62921036 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61113948 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60197050 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59810308 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59269465 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58449198 |
| 69 | Melanoma_Homo sapiens_hsa05218 | 0.57613397 |
| 70 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56142141 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54266762 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53357267 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52286680 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52118678 |
| 75 | Insulin secretion_Homo sapiens_hsa04911 | 0.51457243 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50379743 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49941568 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49592993 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45865568 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44872786 |
| 81 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43901125 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43294087 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41492733 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41436647 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.38644553 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35547400 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31696147 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.31098405 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30754313 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29212812 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28852297 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27272717 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.25681130 |
| 94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25130963 |
| 95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.23916992 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.21851009 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21346118 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.21024776 |
| 99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20400111 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.19755028 |

